In humans, a RCT enrolling 156 patients with a BMI 27 kg/m 2 failed to demonstrate that one year of liraglutide treatment could improve pain in patients with KOA compared to placebo, despite a significant BW difference of approximately 4 kg at end of study 105
[PMC free article: PMC5686559] [PubMed: 29264472] 149
244 Recent research suggests that immunotherapy yielded superior outcomes in obese patients, evidenced by an improved response rate and extended PFS and OS, in comparison to lean patients
Due to this reason, people are actively taking B12 for weight loss to maintain their metabolism levels and burn extra calories
M/S EGMEDI | GSTIN: 07AMZPK2533P1Z8 WB-1 ground floor, Shakarpur, New Delhi-110092, India 2016-2025 All Rights Reserved by EGMEDI In compliance with Drugs and Cosmetics Act 1940 and Drugs and Cosmetics Rules 1945 , we do not process requests for Schedule X and other habit forming drugs.